|
|
Volumn 3, Issue 1, 2001, Pages 30-37
|
|
Pegylated interferons: what role will they play in the treatment of chronic hepatitis C?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALPHA2A INTERFERON;
ALPHA2B INTERFERON;
ANTIVIRUS AGENT;
MACROGOL DERIVATIVE;
PEGINTERFERON ALFA-2A;
PEGINTERFERON ALFA-2B;
PEGINTERFERON ALPHA2A;
PEGINTERFERON ALPHA2B;
RIBAVIRIN;
VIRUS RNA;
BLOOD;
DRUG COMBINATION;
GENETICS;
HEPATITIS C;
HEPATITIS C VIRUS;
HUMAN;
KIDNEY;
METABOLISM;
REVIEW;
ANTIVIRAL AGENTS;
DRUG THERAPY, COMBINATION;
HEPACIVIRUS;
HEPATITIS C, CHRONIC;
HUMANS;
INTERFERON ALFA-2A;
INTERFERON ALFA-2B;
KIDNEY;
POLYETHYLENE GLYCOLS;
RIBAVIRIN;
RNA, VIRAL;
MLCS;
MLOWN;
|
|
EID: 0003071555
PISSN: 15228037
EISSN: None
Source Type: Journal
DOI: 10.1007/s11894-001-0038-z Document Type: Review |
|
Times cited : (43)
|
|
References (68)
|
